Literature DB >> 15339043

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Magda Kucia1, Kacper Jankowski, Ryan Reca, Marcin Wysoczynski, Laura Bandura, Daniel J Allendorf, Jin Zhang, Janina Ratajczak, Mariusz Z Ratajczak.   

Abstract

Chemokines, small pro-inflammatory chemoattractant cytokines, that bind to specific G-protein-coupled seven-span transmembrane receptors present on plasma membranes of target cells are the major regulators of cell trafficking. In addition some chemokines have been reported to modulate cell survival and growth. Moreover, compelling evidence is accumulating that cancer cells may employ several mechanisms involving chemokine-chemokine receptor axes during their metastasis that also regulate the trafficking of normal cells. Of all the chemokines, stromal-derived factor-1 (SDF-1), an alpha-chemokine that binds to G-protein-coupled CXCR4, plays an important and unique role in the regulation of stem/progenitor cell trafficking. First, SDF-1 regulates the trafficking of CXCR4+ haemato/lymphopoietic cells, their homing/retention in major haemato/lymphopoietic organs and accumulation of CXCR4+ immune cells in tissues affected by inflammation. Second, CXCR4 plays an essential role in the trafficking of other tissue/organ specific stem/progenitor cells expressing CXCR4 on their surface, e.g., during embryo/organogenesis and tissue/organ regeneration. Third, since CXCR4 is expressed on several tumour cells, these CXCR4 positive tumour cells may metastasize to the organs that secrete/express SDF-1 (e.g., bones, lymph nodes, lung and liver). SDF-1 exerts pleiotropic effects regulating processes essential to tumour metastasis such as locomotion of malignant cells, their chemoattraction and adhesion, as well as plays an important role in tumour vascularization. This implies that new therapeutic strategies aimed at blocking the SDF-1-CXCR4 axis could have important applications in the clinic by modulating the trafficking of haemato/lymphopoietic cells and inhibiting the metastatic behaviour of tumour cells as well. In this review, we focus on a role of the SDF-1-CXCR4 axis in regulating the metastatic behaviour of tumour cells and discuss the molecular mechanisms that are essential to this process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339043     DOI: 10.1023/b:hijo.0000032355.66152.b8

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  110 in total

1.  SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.

Authors:  R D Chernock; R P Cherla; R K Ganju
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

2.  CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha.

Authors:  I J Crane; C A Wallace; S McKillop-Smith; J V Forrester
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

3.  Chemokine signaling: rules of attraction.

Authors:  Alexander F Schier
Journal:  Curr Biol       Date:  2003-03-04       Impact factor: 10.834

4.  Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation.

Authors:  Rudy Bonavia; Adriana Bajetto; Simone Barbero; Paolo Pirani; Tullio Florio; Gennaro Schettini
Journal:  Toxicol Lett       Date:  2003-04-04       Impact factor: 4.372

Review 5.  Hematologic masquerade of rhabdomyosarcoma.

Authors:  A A Sandberg; J F Stone; L Czarnecki; J D Cohen
Journal:  Am J Hematol       Date:  2001-09       Impact factor: 10.047

6.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

Review 7.  Chemokine receptors.

Authors:  R Horuk
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

8.  Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism.

Authors:  Jean-Jacques Lataillade; Denis Clay; Philippe Bourin; Françis Hérodin; Catherine Dupuy; Claude Jasmin; Marie-Caroline Le Bousse-Kerdilès
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

9.  Signalling pathways involved in the chemotactic activity of CXCL12 in cultured rat cerebellar neurons and CHP100 neuroepithelioma cells.

Authors:  Francesca Floridi; Flavia Trettel; Sabrina Di Bartolomeo; Maria Teresa Ciotti; Cristina Limatola
Journal:  J Neuroimmunol       Date:  2003-02       Impact factor: 3.478

10.  Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion.

Authors:  Natalia Wright; Teresa Laín de Lera; Carelia García-Moruja; Rosa Lillo; Félix García-Sánchez; Antonio Caruz; Joaquin Teixidó
Journal:  Blood       Date:  2003-05-29       Impact factor: 22.113

View more
  270 in total

1.  CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.

Authors:  Bao-Cheng Zhao; Zhen-Jun Wang; Wei-Zheng Mao; Hua-Chong Ma; Jia-Gang Han; Bo Zhao; Hui-Min Xu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  SDF-1α and CXCR4 as therapeutic targets in cardiovascular disease.

Authors:  Jessica Wen; Jian-Qing Zhang; Wei Huang; Yigang Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 3.  Mechanisms driving neural crest induction and migration in the zebrafish and Xenopus laevis.

Authors:  Michael W Klymkowsky; Christy Cortez Rossi; Kristin Bruk Artinger
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

4.  Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach.

Authors:  Masaichi Ogawa; Michiaki Watanabe; Takuo Hasegawa; Kohei Ichihara; Kazuhiko Yoshida; Katsuhiko Yanaga
Journal:  Mol Clin Oncol       Date:  2017-04-04

5.  The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-08-30       Impact factor: 22.113

6.  The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.

Authors:  Brigitte Strahm; Adam D Durbin; Elizabeth Sexsmith; David Malkin
Journal:  Clin Exp Metastasis       Date:  2007-09-01       Impact factor: 5.150

7.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

8.  Gelatin Based Polymer Cell Coating Improves Bone Marrow-Derived Cell Retention in the Heart after Myocardial Infarction.

Authors:  Anuhya Gottipati; Lakshman Chelvarajan; Hsuan Peng; Raymond Kong; Calvin F Cahall; Cong Li; Himi Tripathi; Ahmed Al-Darraji; Shaojing Ye; Eman Elsawalhy; Ahmed Abdel-Latif; Brad J Berron
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 9.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

10.  Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.

Authors:  Xiaoling Liang; Defen Shen; Yongsheng Huang; Chunyue Yin; Christine M Bojanowski; Zhengping Zhuang; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.